# Monarch Casino & Resort Inc: financial statements, quarterly

MCRI · Nasdaq · CIK 907242 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mcri.md) · [Financials](/companies/mcri/financials.md) · [Filings](/companies/mcri/filings.md) · [Insiders](/companies/mcri/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mcri/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [128 d](/filings/0001104659-26-018717.md) | [122](/filings/0001558370-25-006190.md) | [128](/filings/0001558370-25-009717.md) | [138](/filings/0001104659-25-103079.md) | [135 d](/filings/0001104659-26-018717.md) | [125](/filings/0001104659-26-052821.md) | [137](/filings/0001104659-26-087556.md) | [143](/filings/0001104659-26-120630.md) | [140 d](/filings/0001104659-26-018717.md) | [137](/filings/0001104659-26-052821.md) | [143](/filings/0001104659-26-087556.md) | [146](/filings/0001104659-26-120630.md) |
| Gross profit | $m | [25.4 d](/filings/0001104659-26-018717.md) | [23.8](/filings/0001558370-25-006190.md) | [29.5](/filings/0001558370-25-009717.md) | [35.3](/filings/0001104659-25-103079.md) | [3.9 d](/filings/0001104659-26-018717.md) | [25.3](/filings/0001104659-26-052821.md) | [34.9](/filings/0001104659-26-087556.md) | [38.2](/filings/0001104659-26-120630.md) | [29.1 d](/filings/0001104659-26-018717.md) | [34.9](/filings/0001104659-26-052821.md) | [38.6](/filings/0001104659-26-087556.md) | [41.3](/filings/0001104659-26-120630.md) |
| Selling, general and administrative | $m | [28.7 d](/filings/0001104659-26-018717.md) | [27.1](/filings/0001558370-25-006190.md) | [26.2](/filings/0001558370-25-009717.md) | [27.2](/filings/0001104659-25-103079.md) | [27.8 d](/filings/0001104659-26-018717.md) | [27.2](/filings/0001104659-26-052821.md) | [26.8](/filings/0001104659-26-087556.md) | [27.5](/filings/0001104659-26-120630.md) | [27.9 d](/filings/0001104659-26-018717.md) | [27.8](/filings/0001104659-26-052821.md) | [28.6](/filings/0001104659-26-087556.md) | [29.0](/filings/0001104659-26-120630.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.3 d](/filings/0001104659-26-018717.md) | [5.5](/filings/0001558370-25-006190.md) | [6.6](/filings/0001558370-25-009717.md) | [7.5](/filings/0001104659-25-103079.md) | [(0.1) d](/filings/0001104659-26-018717.md) | [5.8](/filings/0001104659-26-052821.md) | [8.3](/filings/0001104659-26-087556.md) | [7.2](/filings/0001104659-26-120630.md) | [6.8 d](/filings/0001104659-26-018717.md) | [8.0](/filings/0001104659-26-052821.md) | [6.8](/filings/0001104659-26-087556.md) | [10.1](/filings/0001104659-26-120630.md) |
| Net income | $m | [18.2 d](/filings/0001104659-26-018717.md) | [18.3](/filings/0001104659-25-103079.md) | [22.7](/filings/0001104659-25-103079.md) | [27.6](/filings/0001104659-25-103079.md) | [4.2 d](/filings/0001104659-26-018717.md) | [19.9](/filings/0001104659-26-120630.md) | [27.0](/filings/0001104659-26-120630.md) | [31.6](/filings/0001104659-26-120630.md) | [22.9 d](/filings/0001104659-26-018717.md) | [27.6](/filings/0001104659-26-120630.md) | [32.5](/filings/0001104659-26-120630.md) | [32.0](/filings/0001104659-26-120630.md) |
| Diluted EPS | $ per share | not reported | [0.93](/filings/0001558370-25-006190.md) | [1.19](/filings/0001558370-25-009717.md) | [1.47](/filings/0001104659-25-103079.md) | not reported | [1.05](/filings/0001104659-26-052821.md) | [1.44](/filings/0001104659-26-087556.md) | [1.69](/filings/0001104659-26-120630.md) | not reported | [1.52](/filings/0001104659-26-052821.md) | [1.78](/filings/0001104659-26-087556.md) | [1.76](/filings/0001104659-26-120630.md) |
| Basic EPS | $ per share | not reported | [0.95](/filings/0001558370-25-006190.md) | [1.21](/filings/0001558370-25-009717.md) | [1.50](/filings/0001104659-25-103079.md) | not reported | [1.08](/filings/0001104659-26-052821.md) | [1.47](/filings/0001104659-26-087556.md) | [1.73](/filings/0001104659-26-120630.md) | not reported | [1.55](/filings/0001104659-26-052821.md) | [1.82](/filings/0001104659-26-087556.md) | [1.80](/filings/0001104659-26-120630.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [75.0](/filings/0001558370-25-002045.md) | [66.5](/filings/0001558370-24-007004.md) | [61.0](/filings/0001558370-24-011610.md) | [68.3](/filings/0001558370-24-015044.md) | [90.4](/filings/0001104659-26-018717.md) | [103](/filings/0001558370-25-006190.md) | [103](/filings/0001558370-25-009717.md) | [134](/filings/0001104659-25-103079.md) | [129](/filings/0001104659-26-120630.md) | [147](/filings/0001104659-26-052821.md) | [169](/filings/0001104659-26-087556.md) | [166](/filings/0001104659-26-120630.md) |
| Total assets | $m | [681](/filings/0001558370-25-002045.md) | [677](/filings/0001558370-24-007004.md) | [672](/filings/0001558370-24-011610.md) | [671](/filings/0001558370-24-015044.md) | [692](/filings/0001104659-26-018717.md) | [712](/filings/0001558370-25-006190.md) | [706](/filings/0001558370-25-009717.md) | [725](/filings/0001104659-25-103079.md) | [713](/filings/0001104659-26-120630.md) | [725](/filings/0001104659-26-052821.md) | [741](/filings/0001104659-26-087556.md) | [736](/filings/0001104659-26-120630.md) |
| Current liabilities | $m | [123](/filings/0001558370-25-002045.md) | [130](/filings/0001558370-24-007004.md) | [136](/filings/0001558370-24-011610.md) | [120](/filings/0001558370-24-015044.md) | [146](/filings/0001104659-26-018717.md) | [149](/filings/0001558370-25-006190.md) | [140](/filings/0001558370-25-009717.md) | [140](/filings/0001104659-25-103079.md) | [150](/filings/0001104659-26-120630.md) | [151](/filings/0001104659-26-052821.md) | [140](/filings/0001104659-26-087556.md) | [142](/filings/0001104659-26-120630.md) |
| Total liabilities | $m | [168](/filings/0001558370-25-002045.md) | [168](/filings/0001558370-24-007004.md) | [174](/filings/0001558370-24-011610.md) | [158](/filings/0001558370-24-015044.md) | [174](/filings/0001104659-26-018717.md) | [176](/filings/0001558370-25-006190.md) | [167](/filings/0001558370-25-009717.md) | [167](/filings/0001104659-25-103079.md) | [175](/filings/0001104659-26-120630.md) | [175](/filings/0001104659-26-052821.md) | [164](/filings/0001104659-26-087556.md) | [167](/filings/0001104659-26-120630.md) |
| Long-term debt | $m | [5.5](/filings/0001558370-25-002045.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [513](/filings/0001104659-26-018717.md) | [509](/filings/0001104659-25-103079.md) | [498](/filings/0001104659-25-103079.md) | [513](/filings/0001104659-25-103079.md) | [518](/filings/0001104659-26-120630.md) | [536](/filings/0001104659-26-120630.md) | [539](/filings/0001104659-26-120630.md) | [558](/filings/0001104659-26-120630.md) | [538](/filings/0001104659-26-120630.md) | [550](/filings/0001104659-26-120630.md) | [577](/filings/0001104659-26-120630.md) | [569](/filings/0001104659-26-120630.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.6 d](/filings/0001104659-26-018717.md) | [38.3](/filings/0001558370-25-006190.md) | [24.3 d](/filings/0001558370-25-009717.md) | [40.3 d](/filings/0001104659-25-103079.md) | [37.8 d](/filings/0001104659-26-018717.md) | [36.5](/filings/0001104659-26-052821.md) | [34.1 d](/filings/0001104659-26-087556.md) | [56.0 d](/filings/0001104659-26-120630.md) | [38.1 d](/filings/0001104659-26-018717.md) | [48.5](/filings/0001104659-26-052821.md) | [30.7 d](/filings/0001104659-26-087556.md) | [50.8 d](/filings/0001104659-26-120630.md) |
| Capital expenditure | $m | [16.8 d](/filings/0001104659-26-018717.md) | [17.6](/filings/0001558370-25-006190.md) | [13.4 d](/filings/0001558370-25-009717.md) | [4.9 d](/filings/0001104659-25-103079.md) | [11.6 d](/filings/0001104659-26-018717.md) | [19.8](/filings/0001104659-26-052821.md) | [8.1 d](/filings/0001104659-26-087556.md) | [2.5 d](/filings/0001104659-26-120630.md) | [5.9 d](/filings/0001104659-26-018717.md) | [5.6](/filings/0001104659-26-052821.md) | [5.2 d](/filings/0001104659-26-087556.md) | [8.9 d](/filings/0001104659-26-120630.md) |
| Dividends paid | $m | [5.7 d](/filings/0001104659-26-018717.md) | [5.7](/filings/0001558370-25-006190.md) | [5.6 d](/filings/0001558370-25-009717.md) | [5.5 d](/filings/0001104659-25-103079.md) | [5.5 d](/filings/0001104659-26-018717.md) | [5.5](/filings/0001104659-26-052821.md) | [5.5 d](/filings/0001104659-26-087556.md) | [5.5 d](/filings/0001104659-26-120630.md) | [5.4 d](/filings/0001104659-26-018717.md) | [5.4](/filings/0001104659-26-052821.md) | [5.4 d](/filings/0001104659-26-087556.md) | [5.3 d](/filings/0001104659-26-120630.md) |
| Share repurchases | $m | not reported | [19.6](/filings/0001558370-25-006190.md) | [30.8 d](/filings/0001558370-25-009717.md) | [9.7 d](/filings/0001104659-25-103079.md) | [(0.1) d](/filings/0001104659-26-018717.md) | not reported | not reported | [11.3 d](/filings/0001104659-26-120630.md) | [41.4 d](/filings/0001104659-26-018717.md) | [17.7](/filings/0001104659-26-052821.md) | [(0.2) d](/filings/0001104659-26-087556.md) | [37.4 d](/filings/0001104659-26-120630.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.7](/filings/0001558370-24-007004.md) | [19.6](/filings/0001558370-24-011610.md) | [19.6](/filings/0001558370-24-015044.md) | [19.7](/filings/0001558370-25-006190.md) | [19.1](/filings/0001558370-25-009717.md) | [18.7](/filings/0001104659-25-103079.md) | [18.8](/filings/0001104659-26-052821.md) | [18.7](/filings/0001104659-26-087556.md) | [18.7](/filings/0001104659-26-120630.md) | [18.2](/filings/0001104659-26-052821.md) | [18.3](/filings/0001104659-26-087556.md) | [18.1](/filings/0001104659-26-120630.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,635,985 at 2026-10-28, from the cover of the [10-Q filed 2026-10-30](/filings/0001104659-26-120630.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Nov 1, 2026, 21:43 ET. No prices; not investment advice.